Your browser doesn't support javascript.
loading
Long-acting reversible contraception use and unmet desire among patients after the Zika Contraception Access Network Program in Puerto Rico.
Stewart, Andrea; Romero, Lisa; Kortsmit, Katherine; Hurst, Stacey; Powell, Rachel; Lathrop, Eva; Whiteman, Maura K; Zapata, Lauren B.
Afiliación
  • Stewart A; Division of Reproductive Health, CDC, Atlanta, GA, United States; Epidemic Intelligence Service, CDC, Atlanta, GA, United States. Electronic address: ouo8@cdc.gov.
  • Romero L; Division of Reproductive Health, CDC, Atlanta, GA, United States.
  • Kortsmit K; Division of Reproductive Health, CDC, Atlanta, GA, United States.
  • Hurst S; Division of Reproductive Health, CDC, Atlanta, GA, United States.
  • Powell R; National Foundation for the Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Lathrop E; Population Services International, Washington, DC, United States.
  • Whiteman MK; Division of Reproductive Health, CDC, Atlanta, GA, United States.
  • Zapata LB; Division of Reproductive Health, CDC, Atlanta, GA, United States.
Contraception ; 135: 110441, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38552819
ABSTRACT

OBJECTIVES:

To describe unmet desire for long-acting reversible contraception (LARC) after the Zika Contraception Access Network (Z-CAN) in Puerto Rico during the 2016-2017 Zika outbreak. STUDY

DESIGN:

Z-CAN patients completed surveys about contraception experiences over a 3-year period.

RESULTS:

Of 1809 respondents, 3% never used LARC but reported wanting it since their initial visit. As reasons for not getting LARC, nearly 50% indicated a provider-related reason and 25% reported cost.

CONCLUSIONS:

Few Z-CAN patients who never used LARC had unmet desire. Provider training in contraception guidelines and strategies to address costs can expand access to the full range of reversible contraception. IMPLICATIONS Three years after a short-term program provided reversible contraception in Puerto Rico, few respondents had never used but wanted a long-acting reversible contraception method. Nearly half reported provider-related reasons for not receiving long-acting reversible contraception, and 25% reported cost. Provider awareness of contraceptive guidance and method availability can support client-centered care.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección por el Virus Zika / Anticoncepción Reversible de Larga Duración / Accesibilidad a los Servicios de Salud Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Caribe / Puerto rico Idioma: En Revista: Contraception Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección por el Virus Zika / Anticoncepción Reversible de Larga Duración / Accesibilidad a los Servicios de Salud Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Caribe / Puerto rico Idioma: En Revista: Contraception Año: 2024 Tipo del documento: Article